-
1
-
-
0032515763
-
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial
-
Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998;351:793-6.
-
(1998)
Lancet
, vol.351
, pp. 793-796
-
-
Cascinelli, N.1
Morabito, A.2
Santinami, M.3
-
2
-
-
0026590057
-
Technical details of intraoperative lymphatic mapping for early-stage melanoma
-
Morton DL, Wen DR, Wong J, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992;127:392-9.
-
(1992)
Arch Surg
, vol.127
, pp. 392-399
-
-
Morton, D.L.1
Wen, D.R.2
Wong, J.3
-
3
-
-
0033958326
-
Standardized probe-directed sentinel node dissection in melanoma
-
Essner R, Bostick PJ, Glass EC, et al. Standardized probe-directed sentinel node dissection in melanoma. Surgery 2000;127:26-31.
-
(2000)
Surgery
, vol.127
, pp. 26-31
-
-
Essner, R.1
Bostick, P.J.2
Glass, E.C.3
-
4
-
-
4344657608
-
Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours
-
Cochran AJ, Roberts A, Wen DR, et al. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours. Pathology 2004;36:478-84.
-
(2004)
Pathology
, vol.36
, pp. 478-484
-
-
Cochran, A.J.1
Roberts, A.2
Wen, D.R.3
-
5
-
-
0032790889
-
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
-
Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;5:442-9.
-
(1999)
Ann Surg Oncol
, vol.5
, pp. 442-449
-
-
Essner, R.1
Conforti, A.2
Kelley, M.C.3
-
6
-
-
0031800249
-
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
-
Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2253-2260
-
-
Gershenwald, J.E.1
Colome, M.I.2
Lee, J.E.3
-
7
-
-
0033497863
-
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
-
Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg 1999;230:453-65.
-
(1999)
Ann Surg
, vol.230
, pp. 453-465
-
-
Morton, D.L.1
Thompson, J.F.2
Essner, R.3
-
8
-
-
24944441877
-
Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-I, an international multicenter trial
-
Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma. Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-13.
-
(2005)
Ann Surg
, vol.242
, pp. 302-313
-
-
Morton, D.L.1
Cochran, A.J.2
Thompson, J.F.3
-
9
-
-
24044509861
-
Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma
-
abstract 7500
-
Morton DL, Thompson JF, Cochran AJ, et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma [abstract 7500]. J Clin Oncol 2005;23:710S.
-
(2005)
J Clin Oncol
, vol.23
-
-
Morton, D.L.1
Thompson, J.F.2
Cochran, A.J.3
-
10
-
-
4344590283
-
Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients
-
Takeuchi H, Morton DL, Kuo C, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 2004;22:2671-80.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2671-2680
-
-
Takeuchi, H.1
Morton, D.L.2
Kuo, C.3
-
11
-
-
4644309225
-
Factors predictive of tumor-positive non-sentinel lymph nodes after tumor-positive sentinel node dissection for melanoma
-
Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive non-sentinel lymph nodes after tumor-positive sentinel node dissection for melanoma. J Clin Oncol 2004;22:3677-84.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3677-3684
-
-
Lee, J.H.1
Essner, R.2
Torisu-Itakura, H.3
Wanek, L.4
Wang, H.5
Morton, D.L.6
-
13
-
-
0034979375
-
Sentinel lymph nodes show profound down-regulation of antigen presenting cells of the paracortex: Implications for tumor biology and treatment
-
Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound down-regulation of antigen presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001;16:604-8.
-
(2001)
Mod Pathol
, vol.16
, pp. 604-608
-
-
Cochran, A.J.1
Morton, D.L.2
Stern, S.3
-
14
-
-
10844242206
-
Lymphangiogenesis and cancer: Meeting report
-
Alitalo K, Mohia S, Ruosiahti E. Lymphangiogenesis and cancer: meeting report. Cancer Res 2004;64:9225-9.
-
(2004)
Cancer Res
, vol.64
, pp. 9225-9229
-
-
Alitalo, K.1
Mohia, S.2
Ruosiahti, E.3
-
15
-
-
0036358039
-
Dendritic cell function in sentinel nodes
-
Huningt.
-
Essner R, Kojima M. Dendritic cell function in sentinel nodes. Oncology (Huningt.) 2002;16:27-31.
-
(2002)
Oncology
, vol.16
, pp. 27-31
-
-
Essner, R.1
Kojima, M.2
-
16
-
-
11344249225
-
Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes
-
Lee JH, Torisu-Itakura H, Cochran AJ, et al. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 2005;11:107-12.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 107-112
-
-
Lee, J.H.1
Torisu-Itakura, H.2
Cochran, A.J.3
-
17
-
-
8544239395
-
Local administration of granulocyte-macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
-
Vaylsteke RJCLM, Molenkamp BG, Giefema HA, et al. Local administration of granulocyte-macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res 2004;64:8456-60.
-
(2004)
Cancer Res
, vol.64
, pp. 8456-8460
-
-
Vaylsteke, R.J.C.L.M.1
Molenkamp, B.G.2
Giefema, H.A.3
|